Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The trial will investigate whether injections of long-acting cabotegravir and rilpivirine yield a superior rate of viral suppression.
A $3.5 million grant to the University of Illinois at Chicago will help researchers find out.
Changes include new information about risks associated with dolutegravir during pregnancy and removal of older drugs owing to toxicities.
The high cost of antiretrovirals may get passed along to consumers through co-pays, co-insurance or deductibles.
A look at 2009 to 2014 data found that those in care for HIV saw a considerable fall in treatment deferrals.
This cheap test could be a good way to assess adherence, unless those who adhere poorly fudge the result by taking a dose before a visit.
The viral suppression rate in this group was considerably higher than that seen in the same clinics a decade before.
A lesson that adherence to HIV medication is a reality, even for long-term survivors
December 2018 Survey
A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)
I pretended I wasn’t scared of anything, but I feared everything.
Researchers have fashioned Truvada tablets that contain a tiny device that communicates adherence data to a skin patch.
This is according to an analysis of young men who have sex with men in Chicago.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.